You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
In a cohort of more than 150 patients, none who responded well to anti-androgen therapy had AR-V7-positive circulating tumor cells detected by Epic's technology.
Researchers presented data suggesting that pharma companies are using basket studies to identify molecularly defined patient subsets who might benefit from their drugs.
The two non-profits have formed a partnership aims at expanding the use of patient data to improve cancer care and precision medicine research.
Genome-wide association and other genetic studies hint at variants increasing subsequent neoplasm risk in individuals treated for cancer during childhood.
Tumor infiltrating cell adoptive cell therapy success in metastatic melanoma patients was associated with DNA methylation and histone acetylation changes.
Using blood samples from more than 15,000 individuals with advanced cancer, researchers identified somatic mutation patterns similar to those in TCGA's database.
Researchers compared precision and non-precision approaches in 346 Phase I studies, and found that personalized medicine improves patient outcomes.
The new rule is aimed at women with early-stage invasive breast cancer and known hormone and HER2 receptor status.
SAP has released products for integrating and analyzing structured and unstructured clinical and genomic datasets, and supporting patient cohort analysis.
The three organizations are inviting comment from health professionals on the recommendations.